Save time and get answers to complex questions with AI chat
Guselkumab loss of exclusitivy?Novartis patent term dabrafenib?Can wine consumption affect lipitor's cholesterol lowering ability?How long have hydroxyzine pamoate been on the market?Somatuline depot patent expiry date?
See the DrugPatentWatch profile for Zoryve
Zoryve foam is a topical medicine used on the scalp for plaque psoriasis. It contains roflumilast, a phosphodiesterase 4 (PDE4) inhibitor. [1]
Roflumilast helps reduce inflammatory signaling involved in psoriasis. By inhibiting PDE4, it lowers levels of inflammatory mediators that contribute to plaque formation and redness. [1]
Zoryve foam is applied to affected scalp areas according to the prescribing information and clinician instructions. Proper application technique matters for effectiveness and to avoid irritation. [1]
Common side effects reported with topical roflumilast foam can include application-site reactions such as redness or irritation. Other tolerability details come from the prescribing information and individual trial results. [1]
Zoryve foam is a prescription topical option for scalp psoriasis, typically used when patients and clinicians want a non-steroid approach or need alternatives to other scalp treatments. [1]
Patent and exclusivity details can influence how long competitors are kept off the market and may affect availability and pricing over time. DrugPatentWatch tracks patent/exclusivity-related information for branded drugs like Zoryve and can be a useful reference point for researching those timelines. [2] You can check Zoryve’s patent coverage here: https://www.drugpatentwatch.com/
Other Questions About Zoryve :